Joanne Xiu

This study identifies chromosome 1q gain as a biomarker for poor immunotherapy response in melanoma by linking aneuploidies to immune evasion mechanisms.

This study shows that inhibiting PIM kinases in tumor-associated macrophages reduces inflammasome activation and improves response to immunotherapy in prostate cancer.

This study investigates how loss of the Y chromosome in lung adenocarcinoma affects the tumor immune environment and response to immunotherapy.

This study compares molecular features of young-onset and average-onset pancreatic cancer using multi-omic data, finding distinct mutation patterns and immune profiles with prognostic implications.